| scholarly article | Q13442814 |
| P2093 | author name string | Yujun Pan | |
| Tongrong He | |||
| Zvonimir S Katusic | |||
| Ruohan Sun | |||
| P2860 | cites work | Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE | Q22010705 |
| Cellular Senescence and the Biology of Aging, Disease, and Frailty | Q26781231 | ||
| Hypertension: a harbinger of stroke and dementia | Q27027494 | ||
| The hallmarks of aging | Q28131641 | ||
| β-secretase inhibitor; a promising novel therapeutic drug in Alzheimer's disease | Q28245473 | ||
| Angiotensin II impairs neurovascular coupling in neocortex through NADPH oxidase-derived radicals | Q28511880 | ||
| Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders | Q29615839 | ||
| Neurovascular regulation in the normal brain and in Alzheimer's disease | Q29619659 | ||
| Angiotensin II type 2 receptor (AT2R) in renal and cardiovascular disease. | Q30249215 | ||
| BACE1 across species: a comparison of the in vivo consequences of BACE1 deletion in mice and rats | Q30361192 | ||
| Angiotensin II attenuates endothelium-dependent responses in the cerebral microcirculation through nox-2-derived radicals | Q33232591 | ||
| Role of neuroinflammation in hypertension-induced brain amyloid pathology | Q33723685 | ||
| The cerebrovascular dysfunction induced by slow pressor doses of angiotensin II precedes the development of hypertension | Q33726694 | ||
| Senescent cells: a novel therapeutic target for aging and age-related diseases | Q33732761 | ||
| An overview of APP processing enzymes and products | Q33927819 | ||
| Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association | Q33967781 | ||
| 'Alzheimer-like' pathology in a murine model of arterial hypertension. | Q33970434 | ||
| Protease nexin-2/amyloid beta-protein precursor limits cerebral thrombosis | Q34212770 | ||
| Targeting the β secretase BACE1 for Alzheimer's disease therapy | Q34405667 | ||
| Vascular aging: insights from studies on cellular senescence, stem cell aging, and progeroid syndromes | Q34818981 | ||
| Angiotensin II receptor type 1--a novel target for preventing neonatal meningitis in mice by Escherichia coli K1. | Q34991058 | ||
| Role of amyloid peptides in vascular dysfunction and platelet dysregulation in Alzheimer's disease | Q35141182 | ||
| ADAM9 inhibition increases membrane activity of ADAM10 and controls α-secretase processing of amyloid precursor protein | Q35562470 | ||
| Angiotensin-(1-7) counteracts angiotensin II-induced dysfunction in cerebral endothelial cells via modulating Nox2/ROS and PI3K/NO pathways | Q35875449 | ||
| Brain-derived neurotrophic factor increases expression of MnSOD in human circulating angiogenic cells | Q35881651 | ||
| Cellular senescence in vivo: its relevance in ageing and cardiovascular disease. | Q36170065 | ||
| Cerebrovascular Damage Mediates Relations Between Aortic Stiffness and Memory | Q36372573 | ||
| β-Secretase (BACE1) inhibition causes retinal pathology by vascular dysregulation and accumulation of age pigment | Q36379519 | ||
| Soluble amyloid precursor protein-α modulates β-secretase activity and amyloid-β generation | Q36462366 | ||
| Activation of protein kinase C modulates BACE1-mediated beta-secretase activity | Q36515891 | ||
| Neurovascular uncoupling in the triple transgenic model of Alzheimer's disease: Impaired cerebral blood flow response to neuronal-derived nitric oxide signaling. | Q50457460 | ||
| Methylation profiling by bisulfite sequencing analysis of the mtDNA Non-Coding Region in replicative and senescent Endothelial Cells | Q61049755 | ||
| Angiotensin II blood-levels in human hypertension | Q93696580 | ||
| AT1 receptor antagonism is proangiogenic in the brain: BDNF a novel mediator. | Q36573232 | ||
| Hypertension enhances Aβ-induced neurovascular dysfunction, promotes β-secretase activity, and leads to amyloidogenic processing of APP | Q36593230 | ||
| Endothelial Dysfunction and Amyloid-β-Induced Neurovascular Alterations. | Q36643093 | ||
| Where hypertension happens | Q36793516 | ||
| Role of Nox isoforms in angiotensin II-induced oxidative stress and endothelial dysfunction in brain | Q37175450 | ||
| Age-related autoregulatory dysfunction and cerebromicrovascular injury in mice with angiotensin II-induced hypertension. | Q37298316 | ||
| Endothelial nitric oxide deficiency promotes Alzheimer's disease pathology | Q37302801 | ||
| TNF-α regulates the proteolytic degradation of ST6Gal-1 and endothelial cell-cell junctions through upregulating expression of BACE1. | Q37587563 | ||
| Angiotensins in Alzheimer's disease - friend or foe? | Q37606768 | ||
| Endothelial nitric oxide: protector of a healthy mind | Q37687314 | ||
| Under pressure: the search for the essential mechanisms of hypertension | Q37953776 | ||
| Roles of amyloid precursor protein family members in neuroprotection, stress signaling and aging | Q37956562 | ||
| Identification and biology of α-secretase. | Q37961730 | ||
| Transcriptional and post-transcriptional regulation of β-secretase. | Q38062499 | ||
| Endothelial cell senescence and age-related vascular diseases | Q38255622 | ||
| Cerebral circulation: function and dysfunction in Alzheimer's disease | Q38266575 | ||
| BACE1 inhibitor drugs in clinical trials for Alzheimer's disease | Q38332419 | ||
| The impact of cerebrovascular aging on vascular cognitive impairment and dementia. | Q38969718 | ||
| Functional vascular contributions to cognitive impairment and dementia: mechanisms and consequences of cerebral autoregulatory dysfunction, endothelial impairment, and neurovascular uncoupling in aging | Q38994143 | ||
| Expression and Processing of Amyloid Precursor Protein in Vascular Endothelium | Q39032252 | ||
| Regulation of Alpha-Secretase ADAM10 In vitro and In vivo: Genetic, Epigenetic, and Protein-Based Mechanisms | Q39214249 | ||
| Cerebral blood flow regulation and neurovascular dysfunction in Alzheimer disease | Q39313671 | ||
| Senescent cells: an emerging target for diseases of ageing | Q39449103 | ||
| ADAM10 is the physiologically relevant, constitutive alpha-secretase of the amyloid precursor protein in primary neurons | Q39672952 | ||
| Risk factors and global cognitive status related to brain arteriolosclerosis in elderly individuals | Q40135861 | ||
| Down-regulation of endogenous amyloid precursor protein processing due to cellular aging | Q40348451 | ||
| The disintegrin ADAM9 indirectly contributes to the physiological processing of cellular prion by modulating ADAM10 activity | Q40360129 | ||
| Angiotensin II receptor subtypes: selective antagonists and functional correlates | Q40504820 | ||
| sAβPPα is a Potent Endogenous Inhibitor of BACE1. | Q40507322 | ||
| On the path to 2025: understanding the Alzheimer's disease continuum | Q41318515 | ||
| Angiotensin II receptors in endothelial cells | Q41623699 | ||
| Hypertension induces brain β-amyloid accumulation, cognitive impairment, and memory deterioration through activation of receptor for advanced glycation end products in brain vasculature | Q42009075 | ||
| ADAM10, the rate-limiting protease of regulated intramembrane proteolysis of Notch and other proteins, is processed by ADAMS-9, ADAMS-15, and the gamma-secretase | Q42059040 | ||
| Angiotensin II activates nuclear transcription factor-kappaB through AT1 and AT2 receptors | Q44004809 | ||
| Impairment of amyloid precursor protein alpha-processing in cerebral microvessels of type 1 diabetic mice | Q47282106 | ||
| BubR1 insufficiency causes early onset of aging-associated phenotypes and infertility in mice | Q47315084 | ||
| BACE1 inhibition reduces endogenous Abeta and alters APP processing in wild-type mice | Q48379491 | ||
| Hypertension accelerates the progression of Alzheimer-like pathology in a mouse model of the disease | Q48479574 | ||
| Substance P activates ADAM9 mRNA expression and induces α-secretase-mediated amyloid precursor protein cleavage | Q48713940 | ||
| Specific Inhibition of β-Secretase Processing of the Alzheimer Disease Amyloid Precursor Protein | Q48873213 | ||
| Role of prostacyclin signaling in endothelial production of soluble amyloid precursor protein-α in cerebral microvessels. | Q49157255 | ||
| Blood angiotensin II levels of normal and hypertensive subjects | Q49169103 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 100-114 | |
| P577 | publication date | 2018-01-15 | |
| P1433 | published in | Aging | Q2845875 |
| P1476 | title | Effects of senescence and angiotensin II on expression and processing of amyloid precursor protein in human cerebral microvascular endothelial cells | |
| P478 | volume | 10 |
Search more.